Loading...
01/10 17:14
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary shows strong financial performance with a 9.5% increase in gross billings and a 7.6% growth in worksite employees. The strategic partnership and client retention are also positive indicators. Although there is a slight decline in staffing revenues and investment income, the company's strong balance sheet and shareholder returns through dividends and buybacks are favorable. The Q&A section revealed no major concerns, and the optimistic guidance of 7% to 9% growth supports a positive outlook. Overall, these factors suggest a positive stock price reaction over the next two weeks.
Gross Billings $2.09 billion in Q1 2025, up 9.5% from $1.91 billion in Q1 2024, driven by new client sales and upselling of products.
PEO Gross Billings $2.07 billion in Q1 2025, up 10% from the prior year, attributed to strong client retention and new client additions.
Staffing Revenues $18 million in Q1 2025, down 10% from the prior year, due to a slowdown in client hiring and macroeconomic headwinds.
Worksite Employees (WSE) Growth 7.6% growth in Q1 2025, driven by a record number of new client additions and improved client retention.
Average Billing per WSE Increased by 2.6% in Q1 2025, impacted by one less business day compared to the prior year.
Workers' Compensation Adjustments Recognized favorable adjustments of $3.8 million in Q1 2025, compared to $3 million in Q1 2024, due to favorable claim frequency trends.
SG&A Expense Increased by approximately 6% in Q1 2025, primarily due to higher employee-related costs, but grew slower than billings growth.
Investment Income $2.6 million in Q1 2025, down $600,000 from the prior year, due to lower average interest rates.
Net Loss per Diluted Share $0.04 in Q1 2025, compared to a net loss of $0.01 per diluted share in the prior year, typical for Q1 due to seasonality.
Unrestricted Cash and Investments $99 million at March 31, 2025, with no debt, indicating a strong balance sheet.
Share Repurchase $9 million of shares repurchased in Q1 2025 at an average price of $39.85 per share, with $21 million remaining under the program.
Dividends Paid $2.1 million in Q1 2025, reaffirming the dividend for the following quarter.
BBSI Benefits: We added approximately 3,000 participants to our various benefits products, with approximately 640 clients on our plans and over 17,500 total participants.
Applicant Tracking System: Launched a new tool that integrates job postings, interview management, and payroll systems, receiving positive feedback from clients.
New Market Expansion: Entered new markets with 21 new market development managers, adding over 600 new worksite employees.
Physical Locations: Planning to open new physical locations in Chicago, Dallas, and Nashville by early third quarter.
Gross Billings Growth: Gross billings increased 9.5% to $2.09 billion in Q1 2025.
Worksite Employees Growth: PEO worksite employees grew by 7.6% in the quarter.
Staffing Operations: Staffing business declined by 10% over the prior year quarter.
Cautious Outlook: Maintaining outlook for billings growth and WSE growth due to economic uncertainty.
Investment in Technology: Continued investment in tech stack to enhance client service and support.
Economic Uncertainty: Trade negotiations and government initiatives are creating a time of uncertainty, which may lead to a slowdown in hiring and company investments.
Client Workforce Changes: Indirect exposure to tariffs could cause clients to reduce or increase their workforce, impacting demand.
Macroeconomic Headwinds: Supply and demand imbalances are affecting staffing operations, leading to a 10% decline in staffing revenues.
Hiring Trends: Client hiring has slowed down in March, which was less than expected, indicating potential challenges in workforce growth.
Regulatory Issues: The company acknowledges potential regulatory impacts that could affect client operations and hiring.
Market Expansion Risks: Entering new markets involves risks associated with local hiring and operational challenges.
Investment Income Decline: Investment income decreased due to lower average interest rates, impacting overall financial performance.
New Client Sales: Record start to the year with new client sales and upselling of new products.
Worksite Employees: Added approximately 7,900 worksite employees year-over-year from net new clients.
Market Expansion: Entered new markets with 21 new market development managers and plans to open physical locations in Chicago, Dallas, and Nashville by early third quarter.
BBSI Benefits: Added approximately 3,000 participants to benefits products, with 640 clients and over 17,500 total participants.
IT Product Objectives: Investing in tech stack to enhance employee life cycle experience and launched BBSI Applicant Tracking System.
Gross Billings Growth: Maintaining outlook for gross billings growth between 7% and 9% for the year.
Worksite Employee Growth: WSE growth outlook maintained between 4% and 6% for the year.
Gross Margin: Gross margin expected between 2.85% and 3.1% of gross billings.
Effective Annual Tax Rate: Expected effective annual tax rate between 26% and 27%.
Dividends Paid: $2.1 million paid in the quarter.
Dividend Outlook: The company reaffirmed its dividend for the following quarter.
Share Repurchase Program: Under a $75 million repurchase program, BBSI repurchased $9 million of shares in Q1 at an average price of $39.85 per share.
Remaining Share Repurchase Capacity: $21 million remaining available under the program at quarter end.
The earnings call summary shows strong financial performance with positive growth in gross billings and worksite employees, and optimistic market opportunities due to inflationary pressures. The Q&A section highlights successful branch openings, a healthy client pipeline, and technological advancements, although some uncertainty remains about the exact impact of the increased healthcare quote pipeline. Overall, the sentiment is positive, driven by growth opportunities, successful expansions, and product development plans.
The earnings call suggests a positive outlook with strong financial performance, growth in new client sales, and market expansion. Despite some regional challenges, the company raised its guidance for the year, indicating confidence in its strategies. The Q&A session highlighted favorable workers' compensation adjustments and technology enhancements aiding market positioning. Although there were some unclear responses, the overall sentiment remains positive, supported by increased net income and strategic expansion plans.
The earnings call summary shows strong financial performance with a 9.5% increase in gross billings and a 7.6% growth in worksite employees. The strategic partnership and client retention are also positive indicators. Although there is a slight decline in staffing revenues and investment income, the company's strong balance sheet and shareholder returns through dividends and buybacks are favorable. The Q&A section revealed no major concerns, and the optimistic guidance of 7% to 9% growth supports a positive outlook. Overall, these factors suggest a positive stock price reaction over the next two weeks.
The earnings call summary presents a mixed picture. While there is strong growth in gross billings and EPS, there are concerns about regulatory issues, staffing business decline, and investment income. The Q&A session indicates stability and recovery but lacks clarity on workers' comp pricing. The strategic partnership with Kaiser Permanente is a positive, but the lack of market cap data limits impact assessment. The shareholder return plan is positive, but economic factors and client payroll tax rates pose risks. Overall, the sentiment is neutral with a slight positive tilt.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
